http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9112784-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3830f35387a1c32061dea3ee310851
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-843
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-844
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
filingDate 1991-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f48ca1854b7b80611727fcf1a44e909d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_604676f613c6fea5543b5f462ad6d32c
publicationDate 1991-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9112784-A1
titleOfInvention Neuropeptide control of ocular growth
abstract A method and medicaments for inhibition of abnormal postnatal ocular growth are disclosed. The method for inhibition of abnormal postnatal ocular growth comprises administering to the eye of an animal effective amount of VIP, PHI or analogue of these peptides. The medicaments of the invention comprise therapeutically effective amounts of a compound selected from the group consisting of vasoactive intestinal peptide, PHI and ocular growth inhibiting analogues of vasoactive intestinal peptide and PHI.
priorityDate 1990-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4745100-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84488
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399716
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6005
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP63289
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7432
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP63290
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81016
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID22353
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2551
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID27151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503384
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87294033
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09685
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48142
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84771
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280956
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP63291
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84772
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP39089
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396323
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID117064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414855934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227980859

Total number of triples: 55.